Loading…
RPG Life Sciences (RPGLIFE)₹2,596+0.66%Pharmaceuticals
At the end of the Sep 2026 quarter, RPG Life Sciences' shareholders were: promoters 72.97%, FIIs 0.86%, DIIs 9.97%, public 16.20%. Promoter holding is unchanged on the quarter. FII holding is down 0.24 percentage points from 1.10% a year earlier. 0.00% of promoter shares were pledged. It had 24,326 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 72.84% | 72.84% | 72.84% | 72.84% | 72.97% | 72.97% | 72.97% | 72.97% | 72.97% | 72.97% | 72.97% | 72.97% |
| FIIs | 0.56% | 0.89% | 1.14% | 1.34% | 1.29% | 1.45% | 1.34% | 1.10% | 0.99% | 0.86% | 0.94% | 0.86% |
| DIIs | 1.78% | 2.18% | 2.63% | 5.49% | 6.10% | 6.18% | 6.53% | 6.74% | 7.08% | 7.49% | 8.72% | 9.97% |
| Public | 24.82% | 24.09% | 23.39% | 20.33% | 19.64% | 19.40% | 19.16% | 19.19% | 18.96% | 18.68% | 17.37% | 16.20% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 21,862 | 22,133 | 22,228 | 23,477 | 24,887 | 24,863 | 25,828 | 26,653 | 25,901 | 25,278 | 23,882 | 24,326 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Nucleus Life Trust (Mr. Harsh Vardhan Goenka is a Trustee) | Promoter | 53.90% | 0.00 |
| Ektara Enterprises Llp | Promoter | 15.60% | 0.00 |
| Clarus Capital I | DII | 6.51% | +0.97 |
| Stel Holdings Limited | Promoter | 3.17% | 0.00 |
| Authum Investment And Infrastructure Limited | DII | 2.03% | 0.00 |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | Public | 1.09% | −0.02 |
| Harshvardhan Goenka | Promoter | 0.16% | 0.00 |
| Mala Goenka | Promoter | 0.05% | 0.00 |
| Carniwal Investments Limited | Promoter | 0.04% | 0.00 |
Promoters held 72.97% of RPG Life Sciences at the end of the Sep 2026 quarter, the same as a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 0.86% (down 0.08 percentage points from 0.94% a quarter earlier) and domestic institutions (DIIs) held 9.97% (up 1.25 percentage points from 8.72% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
RPG Life Sciences had 24,326 shareholders at the end of the Sep 2026 quarter, against 26,653 a year earlier.
Clarus Capital I (DII) held 6.51% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.